97 related articles for article (PubMed ID: 15973076)
1. [Abnormal electron microscopic findings of nonalcoholic steatohepatitis and related factors].
Park KS; Jang BK; Chung WJ; Cho KB; Hwang JS; Ahn SH; Kang YN; Hwang JB; Keum DY
Korean J Gastroenterol; 2005 Jun; 45(6):417-24. PubMed ID: 15973076
[TBL] [Abstract][Full Text] [Related]
2. Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.
Lotowska JM; Sobaniec-Lotowska ME; Bockowska SB; Lebensztejn DM
World J Gastroenterol; 2014 Apr; 20(15):4335-40. PubMed ID: 24764670
[TBL] [Abstract][Full Text] [Related]
3. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?
Ahishali E; Demir K; Ahishali B; Akyuz F; Pinarbasi B; Poturoglu S; Ibrisim D; Gulluoglu M; Ozdil S; Besisik F; Kaymakoglu S; Boztas G; Cakaloglu Y; Mungan Z; Canberk Y; Okten A
J Gastroenterol Hepatol; 2010 Mar; 25(3):619-26. PubMed ID: 20370732
[TBL] [Abstract][Full Text] [Related]
4. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial abnormalities in non-alcoholic steatohepatitis.
Caldwell SH; Swerdlow RH; Khan EM; Iezzoni JC; Hespenheide EE; Parks JK; Parker WD
J Hepatol; 1999 Sep; 31(3):430-4. PubMed ID: 10488700
[TBL] [Abstract][Full Text] [Related]
6. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis.
Le TH; Caldwell SH; Redick JA; Sheppard BL; Davis CA; Arseneau KO; Iezzoni JC; Hespenheide EE; Al-Osaimi A; Peterson TC
Hepatology; 2004 May; 39(5):1423-9. PubMed ID: 15122772
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease.
Sobaniec-Lotowska ME; Lebensztejn DM
Am J Gastroenterol; 2003 Jul; 98(7):1664-5. PubMed ID: 12873608
[No Abstract] [Full Text] [Related]
8. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.
Caldwell SH; Patrie JT; Brunt EM; Redick JA; Davis CA; Park SH; Neuschwander-Tetri BA
Hepatology; 2007 Oct; 46(4):1101-7. PubMed ID: 17661371
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis.
Sobaniec-Łotowska ME; Lebensztejn DM; Lotowska JM; Kańczuga-Koda L; Sulkowski S
Adv Med Sci; 2011; 56(2):172-9. PubMed ID: 21940261
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic findings in patients with nonalcoholic steatohepatitis.
Tanaka N; Ichijo T; Okiyama W; Mutou H; Misawa N; Matsumoto A; Yoshizawa K; Tanaka E; Kiyosawa K
Liver Int; 2006 Feb; 26(1):32-8. PubMed ID: 16420508
[TBL] [Abstract][Full Text] [Related]
13. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
[TBL] [Abstract][Full Text] [Related]
14. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
16. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
17. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
20. [A clinicopathological study on nonalcoholic steatohepatitis].
Lang ZW; Hu ZJ; Wang SK; Zhang LJ; Meng X; Song CZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):81-3. PubMed ID: 12648399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
